|The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST …|
IST-3 Collaborative Group
The Lancet 379 (9834), 2352-2363, 2012
|What should we say to patients with symptoms unexplained by disease? The “number needed to offend”|
J Stone, W Wojcik, D Durrance, A Carson, S Lewis, L MacKenzie, ...
BMj 325 (7378), 1449, 2002
|Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics|
AJ Carson, B Ringbauer, J Stone, L McKenzie, C Warlow, M Sharpe
Journal of Neurology, Neurosurgery & Psychiatry 68 (2), 207-210, 2000
|Systematic review of misdiagnosis of conversion symptoms and “hysteria”|
J Stone, R Smyth, A Carson, S Lewis, R Prescott, C Warlow, M Sharpe
bmj 331 (7523), 989, 2005
|Symptoms ‘unexplained by organic disease’in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?|
J Stone, A Carson, R Duncan, R Coleman, R Roberts, C Warlow, ...
Brain 132 (10), 2878-2888, 2009
|Who is referred to neurology clinics?—the diagnoses made in 3781 new patients|
J Stone, A Carson, R Duncan, R Roberts, C Warlow, C Hibberd, ...
Clinical neurology and neurosurgery 112 (9), 747-751, 2010
|Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus|
BH Anderson, PR Kasher, J Mayer, M Szynkiewicz, EM Jenkinson, ...
Nature genetics 44 (3), 338-342, 2012
|The prognosis of functional (psychogenic) motor symptoms: a systematic review|
J Gelauff, J Stone, M Edwards, A Carson
Journal of Neurology, Neurosurgery & Psychiatry 85 (2), 220-226, 2014
|The symptom of functional weakness: a controlled study of 107 patients|
J Stone, C Warlow, M Sharpe
Brain 133 (5), 1537-1551, 2010
|Functional symptoms and signs in neurology: assessment and diagnosis|
J Stone, A Carson, M Sharpe
Journal of Neurology, Neurosurgery & Psychiatry 76 (suppl 1), i2-i12, 2005
|FMRI in patients with motor conversion symptoms and controls with simulated weakness|
J Stone, A Zeman, E Simonotto, M Meyer, R Azuma, S Flett, M Sharpe
Psychosomatic medicine 69 (9), 961-969, 2007
|Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial|
M Sharpe, J Walker, C Williams, J Stone, J Cavanagh, G Murray, I Butcher, ...
Neurology 77 (6), 564-572, 2011
|Outcome after conservative management or intervention for unruptured brain arteriovenous malformations|
RAS Salman, PM White, CE Counsell, J du Plessis, J van Beijnum, ...
Jama 311 (16), 1661-1669, 2014
|Conversion disorder: current problems and potential solutions for DSM-5|
J Stone, WC LaFrance Jr, R Brown, D Spiegel, JL Levenson, M Sharpe
Journal of psychosomatic research 71 (6), 369-376, 2011
|La belle indifférence in conversion symptoms and hysteria: Systematic review|
J Stone, R Smyth, A Carson, C Warlow
The British Journal of Psychiatry 188 (3), 204-209, 2006
|Disability, distress and unemployment in neurology outpatients with symptoms ‘unexplained by organic disease’|
A Carson, J Stone, C Hibberd, G Murray, R Duncan, R Coleman, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (7), 810-813, 2011
|Physiotherapy for functional motor disorders: a consensus recommendation|
G Nielsen, J Stone, A Matthews, M Brown, C Sparkes, R Farmer, ...
Journal of Neurology, Neurosurgery & Psychiatry 86 (10), 1113-1119, 2015
|Trick or treat?: Showing patients with functional (psychogenic) motor symptoms their physical signs|
J Stone, M Edwards
Neurology 79 (3), 282-284, 2012
|The 12 year prognosis of unilateral functional weakness and sensory disturbance|
J Stone, M Sharpe, PM Rothwell, CP Warlow
Journal of Neurology, Neurosurgery & Psychiatry 74 (5), 591-596, 2003
|Functional (conversion) neurological symptoms: research since the millennium|
AJ Carson, R Brown, AS David, R Duncan, MJ Edwards, LH Goldstein, ...
Journal of Neurology, Neurosurgery & Psychiatry 83 (8), 842-850, 2012